Trial Profile
Open Label Prophylaxis Study of Lithium Plus Extended- Release Carbamazepine (Equetro) Combination for Rapid Cycling Bipolar Disorder.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2012
Price :
$35
*
At a glance
- Drugs Carbamazepine (Primary) ; Lithium (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 12 Nov 2006 New trial record.